开发用于在宫癌中识别哨戒节点的新型标记剂
Keisuke Kodama1, Chuya Tateishi2, Tsuyoshi Oda2
1Department of Obstetrics and Gynecology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Cancer science
|August 30, 2023
概括
一种新的绿色氨酸 (ICG) 标记物ICG-phytate-liposome (LP) 增强了哨兵淋巴结 (SLN) 保留,以改善淋巴图谱. 这种更安全,更持久的追踪器在妇科癌症手术中表现有前途.
科学领域:
- 生物医学工程 生物医学工程
- 医疗成像医学成像
- 纳米技术 纳米技术
背景情况:
- 接近红外线 (NIR) 光成像与内素绿色 (ICG) 对于淋巴细胞映射至关重要.
- 由于与蛋白质结合,ICG在哨兵淋巴结 (SLN) 中的短暂保留限制了其疗效.
- 需要改进的追踪器来增强SLN可视化和保留时间.
研究的目的:
- 开发和评估一种新的光追踪器,ICG-phytate-liposome (LP),用于增强SLN保留.
- 在临床前模型中评估ICG-phytate-LP的安全性和淋巴行为.
- 确定ICG-phytate-LP在改善妇科癌症中淋巴结识别方面的潜力.
主要方法:
- 用最小化的光自灭来准备封装脂体 (LPs) 的氨酸绿 (ICG).
- 通过将LP与植物酸盐和Ca2+混合,制备了ICG-phytate-LP痕迹剂.
- 在小鼠和猪中分析了淋巴结保留时间和淋巴流量.
- 通过猪的死亡率,体重变化和血液测试来评估安全性.
主要成果:
- 一致大小的LP成功封装稳定ICG.
- 在ICG-phytate-LP中,粒子大小增加和表面负电荷增加.
- 在小鼠中,与对照组相比,ICG-phytate-LP在24小时内显示出优异的SLN保留.
- 在猪中,ICG-phytate-LP显示出良好的安全性,没有副作用或血液参数的显著变化.
结论:
- 与单独ICG相比,ICG-phytate-LP显著改善了淋巴结保留时间.
- 在临床前模型中,新型标记剂显示出良好的安全性和有效性.
- 在妇科癌症外科手术中,ICG-phytate-LP具有作为改善淋巴结识别工具的潜力,特别是在逆关节手术中.
相关概念视频
Labeling DNA Probes
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


